Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-31 4:32 pm Purchase | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Integrated Core Strategies (US) LLC | 2,990,279 7.100% | 1,592,897![]() (+113.99%) | Filing History |
| 2024-01-30 4:25 pm Sale | 2023-12-31 | 13G | ROTH CH ACQUISITION CO. CLASS USCT | Integrated Core Strategies (US) LLC | 0 0.000% | -99,254![]() (Position Closed) | Filing History |
| 2024-01-29 4:42 pm Sale | 2023-12-31 | 13G | MILESTONE PHARMACEUTICALS INC MIST | Integrated Core Strategies (US) LLC | 1,730,889 5.200% | -464,140![]() (-21.15%) | Filing History |
| 2024-01-29 4:36 pm Sale | 2023-12-31 | 13G | KALA BIO, INC. KALA | Integrated Core Strategies (US) LLC | 2,653 4.900% | -21![]() (-0.79%) | Filing History |
| 2024-01-26 4:19 pm Sale | 2023-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Integrated Core Strategies (US) LLC | 6,610 0.000% | -981,102![]() (-99.33%) | Filing History |
| 2024-01-25 4:09 pm Purchase | 2024-01-18 | 13G | TERNS PHARMACEUTICALS INC TERN | Integrated Core Strategies (US) LLC | 3,479,630 5.600% | 3,479,630![]() (New Position) | Filing History |
| 2024-01-24 4:16 pm Sale | 2023-12-31 | 13G | BIOLIFE SOLUTIONS INC BLFS | Integrated Core Strategies (US) LLC | 2,412,650 5.400% | -69,296![]() (-2.79%) | Filing History |
| 2024-01-23 4:31 pm Sale | 2023-12-31 | 13G | MYRIAD GENETICS INC MYGN | Integrated Core Strategies (US) LLC | 3,561,337 4.000% | -699,704![]() (-16.42%) | Filing History |
| 2024-01-22 4:15 pm Sale | 2023-12-31 | 13G | TWIST BIOSCIENCE CORP COM TWST | Integrated Core Strategies (US) LLC | 1,821,238 3.200% | -1,224,675![]() (-40.21%) | Filing History |
| 2024-01-22 4:10 pm Sale | 2023-12-31 | 13G | SI-BONE INC SIBN | Integrated Core Strategies (US) LLC | 1,210,324 3.000% | -1,066,163![]() (-46.83%) | Filing History |
| 2024-01-22 4:07 pm Purchase | 2023-12-31 | 13G | EMBECTA CORP COM EMBC | Integrated Core Strategies (US) LLC | 3,635,948 6.300% | 467,043![]() (+14.74%) | Filing History |
| 2024-01-19 4:32 pm Sale | 2023-12-31 | 13G | ZIMVIE INC ZIMV | Integrated Core Strategies (US) LLC | 714,592 2.700% | -763,832![]() (-51.67%) | Filing History |
| 2024-01-19 4:19 pm Sale | 2023-12-31 | 13G | HARPOON THERAPEUTICS INC N HARP | Integrated Core Strategies (US) LLC | 25,465 0.200% | -171,562![]() (-87.08%) | Filing History |
| 2024-01-18 4:40 pm Purchase | 2024-01-08 | 13G | NETSTREIT CORP NTST | Integrated Core Strategies (US) LLC | 3,903,441 5.700% | 3,468,171![]() (+796.79%) | Filing History |
| 2024-01-17 4:54 pm Purchase | 2024-01-10 | 13G | SUTRO BIOPHARMA INC STRO | Integrated Core Strategies (US) LLC | 345,183 5.700% | 345,183![]() (New Position) | Filing History |
| 2024-01-10 4:22 pm Purchase | 2023-12-31 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Integrated Core Strategies (US) LLC | 1,418,675 5.700% | 56,576![]() (+4.15%) | Filing History |
| 2024-01-08 4:32 pm Sale | 2023-12-31 | 13G | AVID BIOSERVICES INC CDMO | Integrated Core Strategies (US) LLC | 4,240,147 6.700% | -354,880![]() (-7.72%) | Filing History |
| 2023-12-19 4:05 pm Purchase | 2023-12-12 | 13G | AVID BIOSERVICES INC CDMO | Integrated Core Strategies (US) LLC | 4,595,027 7.300% | 3,943,316![]() (+605.07%) | Filing History |
| 2023-12-04 4:09 pm Purchase | 2023-11-27 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Integrated Core Strategies (US) LLC | 1,362,099 5.500% | 1,225,913![]() (+900.18%) | Filing History |
| 2023-11-17 4:05 pm Purchase | 2023-11-08 | 13G | MAXCYTE INC MXCT | Integrated Core Strategies (US) LLC | 5,770,894 5.600% | 5,770,894![]() (New Position) | Filing History |

